Prosecution Insights
Last updated: May 29, 2026
Application No. 18/587,088

INITIALIZING MEDICAL DEVICES

Non-Final OA §112
Filed
Feb 26, 2024
Priority
Feb 28, 2023 — provisional 63/448,817
Examiner
HULBERT, AMANDA K
Art Unit
3792
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Itamar Medical Ltd.
OA Round
1 (Non-Final)
84%
Grant Probability
Favorable
1-2
OA Rounds
11m
Est. Remaining
88%
With Interview

Examiner Intelligence

Grants 84% — above average
84%
Career Allowance Rate
630 granted / 748 resolved
+14.2% vs TC avg
Minimal +4% lift
Without
With
+3.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
26 currently pending
Career history
784
Total Applications
across all art units

Statute-Specific Performance

§101
1.6%
-38.4% vs TC avg
§103
68.5%
+28.5% vs TC avg
§102
12.9%
-27.1% vs TC avg
§112
10.8%
-29.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 748 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Claims 148-155 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected Group II, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on January 30, 2026. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 136-147 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 136, lines 1-2 recites the phrase “for initializing an uninitialized home sleep apnea medical device.” It is unclear if the “home sleep apnea device is being functionally or positively recited. It is suggested to positively recite the device before connecting it via a wired or wireless connection with the external programming device. Claim 136, lines 5 and 8 recite method steps of “transmitting a voltage-based index value” and “establishing a wireless connection.” These limitations appear to be placing a method step into an apparatus claim. Allowable Subject Matter Claims 136-147 would be allowable if rewritten or amended to overcome the rejection(s) under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action. The following is a statement of reasons for the indication of allowable subject matter: The prior art of record does not disclose a programming system specific to an uninitialized home sleep apnea medical device that transmits a voltage-based index value via a wired connection and then establishes a wireless connection based on the index value, along with the other elements of the claims. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Jensen et al. (US 2003/0204213), Lee et al. (US 2004/0215095), Kugler et al. (US 2011/0218409), Cho et al (US 2014/0351832), Lynn (USPN 5,891,023) Any inquiry concerning this communication or earlier communications from the examiner should be directed to Amanda K Hulbert whose telephone number is (571)270-1912. The examiner can normally be reached Monday - Friday 9:00-5:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Unsu Jung can be reached at 571-272-8506. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Amanda K Hulbert/Primary Examiner, Art Unit 3792
Read full office action

Prosecution Timeline

Feb 26, 2024
Application Filed
Mar 23, 2026
Non-Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12636508
WEARABLE MEDICAL SYSTEM WITH DEVICE PARAMETERS AND PATIENT INFORMATION PROGRAMMABLE VIA BROWSER INTERFACE
3y 5m to grant Granted May 26, 2026
Patent 12636510
Implantable Pulse Generator Having a Pulse Generation Device
2y 10m to grant Granted May 26, 2026
Patent 12629091
DEVICE, A SYSTEM, AND A METHOD FOR MONITORING BONE DENSITY AND A METHOD FOR IMPLANTING A DEVICE FOR MONITORING BONE DENSITY
3y 6m to grant Granted May 19, 2026
Patent 12629523
Intravaginal Electrical Stimulation Device for Treating Female Pelvic Pain
2y 8m to grant Granted May 19, 2026
Patent 12623069
SELF-SUFFICIENT NEURAL TISSUE STIMULATOR
2y 6m to grant Granted May 12, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
84%
Grant Probability
88%
With Interview (+3.9%)
3y 2m (~11m remaining)
Median Time to Grant
Low
PTA Risk
Based on 748 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month